Author Archives: admin

CMS Meaningful Use Payments to Providers: Incentives or Sophie’s Choice?

Sophie’s Choice: You have to choose when there are no good options. Sophie’s Choice was an award-winning 1983 movie based on the William Styron novel about a Nazi concentration camp survivor who was forced to choose which of her two children to send … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health IT, health policy, health reform | Leave a comment

XPostFactoid Inaugural Hosting of Health Wonk Review: Get It Here

Welcome Andrew Sprung to the Health Wonk Review crew for his debut hosting effort. Click here to read his roundup in the Alternative Facts, Alternative Realities Edition of HWR. Enjoy!

Posted in health economics, health insurance, health IT, health policy | Leave a comment

Healthcare Visionaries Lead the Way

Technology is moving much faster than the snail’s pace of government and regulation. It is an exciting time to be – not just in healthcare – but to be alive. I’ve been hanging around the virtual water cooler in healthcare … Continue reading

Posted in biotechnology, consumer health apps, elearning, electronic patient records, health economics, health insurance, health IT, health IT training, health policy, health reform | Leave a comment

“I Will Build a Great Health Wonk Review”…And He Has!

Brag-a-docious much? Nah, not Jason Shafrin. Our humble Healthcare Economist touts his very biggest, very best, nobody-does-it-better edition of Health Wonk Review right here. Mightily nicely done, there, Mr. Shafrin!

Posted in health economics, health insurance, health policy, health reform | Leave a comment

Health Wonk Review: Groundhog Zombie Goes Back to the Future

With a title like that, who is strong enough to resist clicking on this link to read more? I challenge the most susceptible among you to ignore this post! Julie Ferguson at Workers’ Comp Insider is our creative mistress of ceremonies … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, healthcare marketing | Leave a comment

It’s That Time Again: Play Ball with Health Wonk Review

  Enjoy the Whos’ On First Edition with Brad Wright with Wright on Health. Here’s the link to all the facts.

Posted in Uncategorized | Leave a comment

InsureBlog Hosts the Pre-Passover Edition of Health Wonk Review

        Yes, it is that time again! Oh, sure, the biweekly Health Wonk Review is on your newsstand today. But also, those religious rites of spring are right around the corner. So without further ado or comment … Continue reading

Posted in Uncategorized | Leave a comment

AHCA: Aye or Nay Edition of Health Wonk Review

March 23, 2017 By Louise Norris Seven years ago today, President Obama signed the Affordable Care Act into law, ushering in a host of reforms for the U.S. health care system. And today, House Republicans are planning to vote on the … Continue reading

Posted in health economics, health insurance, health policy, health reform | Leave a comment

A Policy Decision: Choosing Between Health Insurance and Medical Care

Those who control the language, control the debate. The question on the table in the U.S. today is, “What is the most efficient and least costly way to provide health insurance coverage to everyone?” Coverage is such a nice word. … Continue reading

Posted in electronic patient records, health economics, health insurance, health IT, health policy, health reform | Leave a comment

The “May You Live in Interesting Times” Edition of Health Wonk Review

Just when you thought things can’t get any weirder, they do. Combine staunch opposed ideologies held by fierce political warriors, and we find ourselves under the ancient curse of living in interesting times. It seems our nation is transitioning from … Continue reading

Posted in biotechnology, consumer health apps, electronic patient records, health economics, health insurance, health IT, health policy, health reform, pharmaceutical marketing | 6 Comments